Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development.

Area of Science:

• Pharmacometrics
• Computational Biology
• Drug Development

Background:

• Lack of a standardized exchange format for mathematical models in pharmacometrics hinders productivity and data sharing.
• Current methods for model handling are complex and can compromise research reproducibility.
• Need for a common language to facilitate collaboration and model reuse in drug disease modeling.

Purpose of the Study:

• Introduce Pharmacometrics Markup Language (PharmML) as a proposed solution.
• To establish a universal standard for encoding pharmacometric models, trial designs, and analysis workflows.
• To enhance productivity, analysis quality, and reproducibility in pharmacometric research.

Main Methods:

• Development of Pharmacometrics Markup Language (PharmML) by the Drug Disease Model Resources (DDMoRe) consortium.
• Defining a structured format for representing mathematical models, experimental designs, and computational steps.
• Focus on creating an extensible and interoperable standard.

Main Results:

• PharmML is under development to provide a common exchange format.
• The language aims to encode models, trial designs, and modeling steps.
• Potential to streamline workflows and improve model resource reuse.

Conclusions:

• Pharmacometrics Markup Language (PharmML) offers a promising solution to the long-standing problem of a common exchange format.
• Adoption of PharmML can significantly improve the efficiency, quality, and reproducibility of pharmacometric research.
• Facilitates seamless integration and reuse of pharmacometric models and associated data.